D.E. Shaw & Co’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-82,578
| Closed | -$3.32M | – | 3193 |
|
|
2024
Q4 | $3.32M | Sell |
82,578
-105,619
| -56% | -$4.25M | ﹤0.01% | 1525 |
|
|
2024
Q3 | $8.91M | Sell |
188,197
-107,375
| -36% | -$5.08M | 0.01% | 997 |
|
|
2024
Q2 | $8.82M | Buy |
295,572
+227,810
| +336% | +$6.8M | 0.01% | 958 |
|
|
2024
Q1 | $2.72M | Buy |
+67,762
| New | +$2.72M | ﹤0.01% | 1601 |
|
|
2023
Q2 | – | Sell |
-27,032
| Closed | -$801K | – | 3226 |
|
|
2023
Q1 | $801K | Buy |
27,032
+13,553
| +101% | +$402K | ﹤0.01% | 2313 |
|
|
2022
Q4 | $336K | Buy |
13,479
+2,662
| +25% | +$66.4K | ﹤0.01% | 2859 |
|
|
2022
Q3 | $235K | Buy |
+10,817
| New | +$235K | ﹤0.01% | 3161 |
|
|
2021
Q2 | – | Sell |
-14,645
| Closed | -$569K | – | 3650 |
|
|
2021
Q1 | $569K | Sell |
14,645
-16,947
| -54% | -$658K | ﹤0.01% | 2452 |
|
|
2020
Q4 | $1.96M | Buy |
+31,592
| New | +$1.96M | ﹤0.01% | 1737 |
|